Clinical Trial Update: Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP) [Phase 2]

View source ↗

Summary

Phase 2 long-term safety and efficacy outcome study in children previously enrolled for prevention of retinopathy of prematurity (ROP) has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Snippet

Sponsor: Shire | Conditions: Retinopathy of Prematurity (ROP) | Phase 2 | Status: COMPLETED | Results posted: 2022-04-25